Bariatric surgery in patients with non-alcoholic fatty liver disease-from pathophysiology to clinical effects

• 作者: Christoffer A Hagemann Chunshan Wei Filip K Knop Henning Grφb?k Karen L Thomsen Konstantin Kazankov Tea L Laursen
• 来源期刊: 世界肝病学杂志:英文版(电子版)
• 学科: 医学
• 关键词: Non-alcoholic fatty liver disease Non-alcoholic STEATOHEPATITIS BARIATRIC surgery Insulin resistance Gut hormones Glucagon-like peptide 1 STEATOSIS Inflammation Fibrosis
• 年，卷（期）: 2019,（2）
• 页码范围: 138-149
• 页数: 12页
• 分类号: R

摘要

Non-alcoholic fatty liver disease(NAFLD)is increasingly recognized as a significant liver disease,and it covers the disease spectrum from simple steatosis with a risk of development of non-alcoholic steatohepatitis(NASH)to fibrosis,subsequent cirrhosis,end-stage liver failure,and liver cancer with a potential need for liver transplantation.NAFLD and NASH are closely related to obesity,metabolic syndrome,and type 2 diabetes(T2D).The role of gut hormones,especially glucagon-like peptide 1(GLP-1),is important in NAFLD.Bariatric surgery has the potential for inducing great weight loss and may improve the symptoms of metabolic syndrome and T2D.Recent data demonstrated significant effects of bariatric surgery on GLP-1 and other gut hormones and important lipid metabolic and inflammatory abnormalities in the pathophysiology of NAFLD.Therefore,bariatric surgery may reverse the pathological liver changes in NAFLD and NASH patients.In the present review,we describe NAFLD and NASH pathophysiology and the primary effects of bariatric surgery on metabolic pathways.We performed a systematic review of the beneficial and harmful effects and focused on changes in liver disease severity in NAFLD and NASH patients.The specific focus was liver histopathology as assessed by the invasive liver biopsy.Additionally,we reviewed several non-invasive methods used for the assessment of liver disease severity following bariatric surgery.